WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012114354) ANHYDROUS LINEZOLID CRYSTALLINE FORM-II
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/114354    International Application No.:    PCT/IN2012/000120
Publication Date: 30.08.2012 International Filing Date: 21.02.2012
IPC:
C07D 263/20 (2006.01)
Applicants: LEE PHARMA LIMITED [IN/IN]; Sy. No. 257 & 258 /1 Door No. 11-6-56, C Block Opp. IDPL Factory, Moosapet (Village), Balanagar (Post) Hyderabad 500037 (IN) (For All Designated States Except US).
ALLA, Raghu Mitra [IN/IN]; (IN) (For US Only).
DUBEY, Ajay Kumar [IN/IN]; (IN) (For US Only).
SIRIGIRI, Aruna Kumari [IN/IN]; (IN) (For US Only).
MAREEDU, Naga Karna Kumar [IN/IN]; (IN) (For US Only)
Inventors: ALLA, Raghu Mitra; (IN).
DUBEY, Ajay Kumar; (IN).
SIRIGIRI, Aruna Kumari; (IN).
MAREEDU, Naga Karna Kumar; (IN)
Agent: HASAN, Afzal; Hasan And Singh Flat No. 1-A, C. O. D. Staff Apartment Hitech City Main Road, (Near ING Vysya Bank) Cyberabad Post, Madhapur Hyderabad 500081 (IN)
Priority Data:
2450/CHE/2010 24.02.2011 IN
Title (EN) ANHYDROUS LINEZOLID CRYSTALLINE FORM-II
(FR) FORME II CRISTALLINE ANHYDRE DE LINÉZOLIDE
Abstract: front page image
(EN)The present invention relates to oxazolidinone antibacterial agent anhydrous Linezolid crystalline Form-II. The anhydrous Linezolid crystalline Form-II of the invention comprises less than 0.5% of water content. The anhydrous Linezolid crystalline Form-II of the invention is characterized by the XRPD spectrum and IR spectrum described in the specification.
(FR)La présente invention concerne une forme II cristalline anhydre de linézolide, un oxazolidinone antibactérien. La forme II cristalline anhydre de linézolide de l'invention comprend moins de 0,5% de teneur en eau. La forme II cristalline anhydre de linézolide de l'invention est caractérisée par le spectre XRPD et le spectre IR, mentionnés dans la description.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)